Dow Dividend Stock #8 – Johnson & Johnson (JNJ)
|Market Cap: $164.1 billion
Manufacturer and marketer of health care products Johnson & Johnson (JNJ) has continually exceeded earnings estimates each of the last four quarters, and is looking to continue the trend. While Johnson & Johnson’s dividend yield is lower than similar pharma and medical companies at 3.6%, JNJ’s stock has outperformed major competitor Pfizer (PFE) considerably in 2010. With a recent quarterly revenue of $16.8 billion and a strong history of dividend payouts, Johnson & Johnson remains a stable choice in the healthcare industry.